These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15613032)

  • 1. Tissue factor pathway inhibitor revisited.
    Hjort PF; Sandset PM; Abildgaard U; Rao LV; Mast A; Ott I; Bajaj SP
    J Thromb Haemost; 2004 Dec; 2(12):2241-9. PubMed ID: 15613032
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood clotting and coagulation factors: the work of Yale Nemerson. 1980, 1982.
    Kresge N; Simoni RD; Hill RL
    J Biol Chem; 2011 Jul; 286(26):e5-6. PubMed ID: 21842549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Curr Stud Hematol Blood Transfus; 1991; (58):22-5. PubMed ID: 1954769
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tissue factor and inhibitor of the blood coagulation pathway in nephrotic syndrome].
    Małyszko JS; Małyszko J; Myśliwiec M
    Pol Arch Med Wewn; 1999 Apr; 101(4):301-5. PubMed ID: 10740407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tissue factor pathway inhibitor in a revised coagulation cascade.
    Broze GJ
    Semin Hematol; 1992 Jul; 29(3):159-69. PubMed ID: 1641662
    [No Abstract]   [Full Text] [Related]  

  • 6. Extrinsic coagulation pathway inhibitor during recombinant factor VIIa infusion.
    Sandset PM; Abildgaard U; Hedner U; Johansson H
    Thromb Haemost; 1989 Dec; 62(4):1146. PubMed ID: 2617462
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue factor and hemostasis.
    Nemerson Y
    Blood; 1988 Jan; 71(1):1-8. PubMed ID: 3275472
    [No Abstract]   [Full Text] [Related]  

  • 8. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
    Sandset PM; Abildgaard U
    Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipoproteins enhance tissue factor-independent factor VII activation.
    Kjalke M; Silveira A; Hamsten A; Hedner U; Ezban M
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1835-41. PubMed ID: 10894826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
    Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
    Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation.
    Rapaport SI
    Thromb Haemost; 1991 Jul; 66(1):6-15. PubMed ID: 1926052
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood coagulation and fibrinolysis: an overview.
    Mosher DF
    Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI5-11. PubMed ID: 2191814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitors of the tissue factor:factor VII pathway.
    Golino P
    Thromb Res; 2002 May; 106(3):V257-65. PubMed ID: 12356487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modification effect of the protein component of tissue thromboplastin (factor III) on its interaction with factors VII and X].
    Zubairov DM; Baĭkeev RF; Byshevskiĭ ASh; Tersenov OA
    Biokhimiia; 1984 Jun; 49(6):971-5. PubMed ID: 6466743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the inhibition of tissue factor in serum.
    Broze GJ; Miletich JP
    Blood; 1987 Jan; 69(1):150-5. PubMed ID: 3024756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor.
    Kondo S; Kisiel W
    Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of the protein and phospholipid components of tissue thromboplastin (factor III) with the factors VII and X.
    Bjorklid E; Storm E; Osterud B; Prydz H
    Scand J Haematol; 1975 Mar; 14(1):65-70. PubMed ID: 1121648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood.
    Abildgaard U; Lindahl AK; Sandset PM
    Haemostasis; 1991; 21(4):254-7. PubMed ID: 1794751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.